Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 56 citing Krssak: Alterations in postprandial hepatic glycogen metabolism in type 2 diabetes. (0.08 sec) 

Mechanisms of disease: hepatic steatosis in type 2 diabetes—pathogenesis and clinical …


M Roden - Nature Reviews Endocrinology, 2006 - nature.com
Hepatic steatosis is defined by an increased content of hepatocellular lipids
(HCLs) and is frequently observed in insulin-resistant states including type 2
diabetes mellitus. A dietary excess of saturated fat contributes ...
Cited by 73 - Related articles - BL Direct - All 4 versions

Overactivation of S6 kinase 1 as a cause of human insulin resistance during increased amino …


F Tremblay, M Krebs, L Dombrowski, A Brehm, … - Diabetes, 2005 - Am Diabetes Assoc
To examine the molecular mechanisms by which plasma amino acid elevation impairs
insulin action, we studied seven healthy men twice in random order during
infusion of an amino acid mixture or saline (total plasma amino acid ∼6 ...
Cited by 58 - Related articles - BL Direct - All 5 versions

Increased lipid availability impairs insulin-stimulated ATP synthesis in human skeletal …


A Brehm, M Krssak, AI Schmid, P Nowotny, W … - Diabetes, 2006 - Am Diabetes Assoc
Insulin resistance correlates with intramyocellular lipid content (IMCL) and
plasma free fatty acids (FFAs) and was recently linked to mitochondrial
dysfunction. We examined the underlying relationships by measuring skeletal ...
Cited by 56 - Related articles - BL Direct - All 7 versions

Real-time assessment of postprandial fat storage in liver and skeletal muscle in health and …

- physiology.org
B Ravikumar, PE Carey, JEM Snaar, DK … - American Journal of Physiology- Endocrinology And …, 2005 - Am Physiological Soc
Liver and skeletal muscle triglyceride stores are elevated in type 2 diabetes
and correlate with insulin resistance. As postprandial handling of dietary fat
may be a critical determinant of tissue triglyceride levels, we quantified ...
Cited by 41 - Related articles - All 4 versions

Effects of insulin therapy on liver fat content and hepatic insulin sensitivity in patients with …

- physiology.org
L Juurinen, M Tiikkainen, AM Hakkinen, A … - American Journal of Physiology- Endocrinology And …, 2007 - Am Physiological Soc
We determined whether insulin therapy changes liver fat content (LFAT) or
hepatic insulin sensitivity in type 2 diabetes. Fourteen patients with type 2
diabetes (age 51 ± 2 yr, body mass index 33.1 ± 1.4 kg/m 2 ) treated with ...
Cited by 20 - Related articles - BL Direct - All 8 versions

[PDF] Physiogenomic analysis of weight loss induced by dietary carbohydrate restriction


G Ruaño, A Windemuth, M Kocherla, T … - Nutrition & Metabolism, 2006 - biomedcentral.com
Page 1. ...
Cited by 15 - Related articles - View as HTML - All 14 versions

Effects of free fatty acids on carbohydrate metabolism and insulin signalling in perfused rat …


C Anderwald, B Brunmair, K Stadlbauer, M … - European Journal of Clinical Investigation, 2007 - interscience.wiley.com
It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ...
Cited by 10 - Related articles - BL Direct - All 3 versions

[PDF] Glucokinase and molecular aspects of liver glycogen metabolism


L Agius - Biochemical Journal, 2008 - eng.auburn.edu
Conversion of glucose into glycogen is a major pathway that contributes to the
removal of glucose from the portal vein by the liver in the postprandial state.
It is regulated in part by the increase in blood-glucose concentration in ...
Cited by 10 - Related articles - View as HTML - All 5 versions

Effect of pioglitazone on the metabolic and hormonal response to a mixed meal in type II …


A Gastaldelli, A Casolaro, M Pettiti, M … - Clinical Pharmacology & Therapeutics, 2007 - nature.com
We explored the mechanisms by which a 4-month, placebo-controlled pioglitazone
treatment (45 mg/day) improves glycemic control in type II diabetic patients
(T2D, n=27) using physiological testing (6-h mixed meal) and a triple ...
Cited by 8 - Related articles - All 4 versions

The role of endocrine counterregulation for estimating insulin sensitivity from intravenous …

- endojournals.org
A Brehm, K Thomaseth, E Bernroider, P … - Journal of Clinical Endocrinology & Metabolism, 2006 - Endocrine Soc
Design: All participants were studied in random order during IM-FSIGT (0.3 g/kg
glucose; 0.03 U/kg insulin at 20 min) and during identical conditions but with a
variable glucose infusion preventing a decrease of plasma glucose ...
Cited by 8 - Related articles - BL Direct - All 4 versions


Result Page: 

1

2

3

4

5

6

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google